1204580-72-2 Usage
Uses
Used in Organic Synthesis:
2-Methoxy-4-(tributylstannyl)pyridine is used as a reagent for the preparation of various functionalized pyridine derivatives, which are important building blocks in the synthesis of complex organic molecules.
Used in Pharmaceutical Synthesis:
2-Methoxy-4-(tributylstannyl)pyridine is employed as an intermediate in the synthesis of pharmaceutical agents, contributing to the development of new drugs with potential therapeutic applications.
Used in Electronic Materials:
2-Methoxy-4-(tributylstannyl)pyridine is used in the synthesis of materials for electronic devices, such as organic semiconductors and other components, due to its unique chemical properties.
Used in Chemical Research:
As an important intermediate, 2-Methoxy-4-(tributylstannyl)pyridine is utilized in chemical research to explore new reaction pathways and develop innovative synthetic methods.
Check Digit Verification of cas no
The CAS Registry Mumber 1204580-72-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,4,5,8 and 0 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1204580-72:
(9*1)+(8*2)+(7*0)+(6*4)+(5*5)+(4*8)+(3*0)+(2*7)+(1*2)=122
122 % 10 = 2
So 1204580-72-2 is a valid CAS Registry Number.
1204580-72-2Relevant academic research and scientific papers
Palladium-Catalyzed gem-Difluoroallylation Reaction between Aryltributyltin and Bromodifluoromethylated Alkenes
Chen, Xiao-Qu,Lu, Heng,Chen, Chuan-Xin,Zeng, Ruoqing,Wang, Dong-Yu,Shi, Chang-Yun,Zhang, Ao
supporting information, p. 2935 - 2946 (2022/02/10)
A robust Stille gem-difluoroallylation of arylstannanes with 3-bromo-3,3-difluoropropenes has been established. The catalyst was found to exert critical effect on the reaction chemoselectivity. By using Pd(OH)2/C as the catalyst, a series of 3-(hetero)ary
PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS
-
Page/Page column 4, (2019/03/05)
Described herein are compounds that activate pyruvate kinase R, pharmaceutical compositions and methods of use thereof. These compounds are represented by Formula (I): Formula (I) wherein R', R2, L', and L2 are as defined herein.
